Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding

Hypertension

Volumn 43, Issue 6, 2004, Pages 1258-1263

  Hiyoshi, Hiromi ^a   Yayama, Katsutoshi ^a   Takano, Masaoki ^a   Okamoto, Hiroshi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Bradykinin; Cyclic GMP; Nitric oxide; Receptors, angiotensin II; Vasodilation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; CYCLIC GMP; ICATIBANT; KININ; LOSARTAN; MESSENGER RNA;

ABDOMINAL AORTA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GASTRIC BANDING; HYPERTENSION; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSURE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; STIMULATION; THORACIC AORTA; VASCULAR RING; VASODILATATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; AORTIC VALVE STENOSIS; BRADYKININ; CYCLIC GMP; HYPERTENSION; IMIDAZOLES; LIGATION; LOSARTAN; MALE; MICE; MICE, INBRED ICR; MODELS, ANIMAL; NITRIC OXIDE; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTOR, BRADYKININ B2; RENIN; RNA, MESSENGER; UP-REGULATION; VASOCONSTRICTION;

EID: 2542446284     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000128022.24598.4f     Document Type: Article

References (22)

1. de Gasparo M, Catt KJ, Inagami T, Wright W, Unger TH. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
2. Akishita M, Yamada H, Dzau VJ, Horiuchi M. Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor. Biochem Biophys Res Commun. 1999;261:345-349.
3. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 1995;377:744-747.
4. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925-935.
5. 1 receptor antagonist in hypertensive rats. Hypertension. 1999;34:1112-1116.
6. 2 receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Brit J Pharmacol. 2002;136:484-491.
7. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
8. Viswanathan M, Tsutsumi K, Correa FMA, Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun. 1991;179:1361-1367.
9. Inagami T. Molecular biology and signaling of angiotensin receptors: an overview. J Am SocNephrol. 1999;10(suppl 11):S2-S7.
10. Yayama K, Horii M, Hiyoshi H, Takano M, Okamoto H, Kagota S, Kunitomo M. Upregulation of angiotensin II type 2 receptor in rat thoracic aorta by pressure-overload. J Pharmacol Exp Ther. 2004;308:736-743.
11. Wirth KJ, Linz W, Wiemer G, Scholkens BA. Differences in acetylcholine- and bradykinin-induced vasorelaxation of the mesenteric vascular bed in spontaneously hypertensive rats of different ages. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:38-43.
12. 2-receptor, kallikrein and kininogen mRNAs in the heart are altered in pressure-overload cardiac hypertrophy in mice. Biol Pharm Bull. 2001;24:34-38.
13. Ohtani R, Ohashi Y, Muranaga K, Itoh N, Okamoto H. Changes in activity of the renin-angiotensin system of the rat by induction of acute inflammation. Life Sci. 1989;44:237-241.
14. 2-receptor mRNA in the heart in pressure-overload cardiac hypertrophy in the rat. Biochem Pharmacol. 2003;65:1017-1025.
15. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
16. 2 production in conscious rats. J Clin Invest. 1996;97:1978-1982.
17. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.
18. Carey RM, Howell NL, Jin X-H, Siragy HM. Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension. 2001;38:1272-1277.
19. 1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol. 2003;140:987-995.
20. Miura S, Kamik SS. Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis. EMBO J. 2000;19:4026-4035.
21. Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Freming BR. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension. 1997;30:934-941.
22. Barton CH, Ni Z, Vaziri ND. Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression. Kidney Int. 2001;59:654-661.